Here you can read all news about stem cells.
Here you can read all news about stem cells.
09 October 2019
How Can Stem Cells Help in the Treatment of Autism?
The Scientific Basis of Autism Treatment with Stem Cells – Clinical Trials
What Are the Expected Results?
Patient Outcomes and Testimonials of Autism Treatment with Stem Cells
Swiss Medica Success Rate for Patients with Autism
What is the Procedure for Stem Cell Therapy?
Age, Autism and Stem Cell Therapy
When Can a Patient Expect to See Improvement?
Are There Potential Side Effects?
List of References
Autism is a disorder of neural development characterized by impaired social interactions (communication), mood alterations, repetitive behavior, along with metabolic, immune and digestive issues, sleep disorders, learning disabilities, as well as problems with memory, thinking and speech. There is also autism spectrum disorder (ASD) which is described as a range of conditions inherent in a number of neurological disorders .
Autism is assumed to be a congenital disorder caused by impaired information processing in the brain by altering how nerve cells connect and organize. This disorder cannot be completely eliminated by conventional therapies. The conservative treatment of these pathologies includes both educational interventions and medical management. More than half of children diagnosed with autism are prescribed psychoactive drugs or anticonvulsants.
Conventional treatment also includes social skills training, early intensive behavioral therapy, applied behavior analysis (ABA therapy), speech therapy, transcranial magnetic stimulation, cognitive-behavioral therapy, and possibly even hormone therapy. But the matter is that the conventional drugs that are prescribed in autism only smooth out the specific symptoms, targeting only one or two of them, while causing unwanted side effects that can be problematic for both the child as well as their caregivers.
Treating autism with stem cells offers an entirely new tool for parents and patients to explore. The prospective approach is based on the unique capacity of stem cells to positively influence the immune system and metabolism, as well as their ability to restore damaged cells and tissues. This treatment favorable affects every organ and system of the body, including the brain.
Get a free online consultation from a Medical Advisor to find out if stem cells would work for you >>>
When autism is diagnosed, it means that areas of the brain regulating memory, concentration, attention, speech are damaged. The main goal of stem cell therapy is to trigger brain development, and then the child’s body does its own work to repair damaged cells.
First of all, therapeutic results are reached through the restoration of the lost or impaired neuronal connections, as well as through the formation of the new neuron connections by secretion of neurotrophic factors. Due to the improvement of synaptic transmission, the reaction speed in the brain increases, leading to a reduction in autism symptoms , .
Stem cell treatment improves blood and oxygen flow in the brain (improved perfusion) and stimulates the replacement of damaged neurons and the formation of the new blood vessels . Injected stem cells also stimulate the multiplication of cells of damaged tissue, which in the case of autism results in white matter restoration and, consequently, in subsidence of neurologic symptoms and improved intellectual capacity .
Autism is also accompanied by a decrease in immunity, so the capability of mesenchymal stem cells to improve the immune system and terminate inflammation throughout the body is beneficial too. Stem cells are able to produce anti-inflammatory cytokines, which are special protein molecules involved in modulating the immune system .
Several studies have been conducted to explore the safety and efficacy of cellular products in autism management. Improvements have been recorded in the Childhood Autism Rating Scale (CARS), Clinical Global Impression (CGI) scale, and Aberrant Behavior Checklist (ABC) in children treated with stem cells when compared to the control group .
In particular, there are enhancements in the field of social relationships and reciprocity (improved eye contact, social smile, and reaching out to others), cognitive aspects (attention, concentration, and time of response), and also in speech and language patterns (reduction in echolalic speech, engaging in regular use of language, improvement in the ability to initiate or sustain conversation, reduction in speech regression). At the same time, after treatment with stem cells, the frequency of undesirable reactions decreased (inappropriate emotional responses, engaging in self-stimulating emotions, and excessive and unwarranted agitation or excitement for no acceptable reason).
Clinical and statistical data is further confirmed by the results of instrumental studies before and after cell therapy. They have shown that the introduction of stem cells improves metabolism in hypometabolic areas in the brain. This is probably due to improved oxygenation, blood flow and the improved functioning of the neurons .
Based on the experience of the Swiss Medica clinical practice, we have identified the following improvements in autism after therapy based on adult (non-fetal and non-embryonic) stem cells:
• Better tolerance of food (generally) and improved digestion.
• More amicable contact with the child (first of all, eye contact). Children are likely to begin fixing their gaze or maintaining eye contact.
• More appropriate behavior at home and outside (less hyperactivity and aggression, fewer obsessions, repetitive behavior, or compulsive motor mannerisms; improved listening, especially to parental expectations, rules, and requests).
• Improved verbal communication skills (if the child is non-verbal, he or she is very likely to start exploring sounds, syllables, and then pronounce words; increased vocabulary in verbal children).
• Improved learning ability through increased attention span and concentration. Writing skills develop or improve.
• Improved self-care skills, more likely to communicate needs and complete hygiene routines autonomously and reliably.
• Anxiety reduction. Less or no fear of loud noises, strangers and bright colors (gradual improvement). Fear of unfamiliar people and places is often reduced or relieved, as well.
• Improved sleep patterns.
Get a free online consultation to get more information on the expected results of stem cell treatment for your case >>>
We have treated more than 180 patients diagnosed with autism in our clinics in Moscow and Belgrade, in which stem cell treatment for this disorder is performed. Here are some results of the therapy.
1. «Since we had stem cell treatment it has been a nine-month. It’s unbelievable how our life has changed»:
2. «In spite everybody says there is no cure for autism, we always considered doing as much as we can in order to help him to have a better life»:
More examples of stem cell treatment for autism patients in Swiss Medica clinics can be watched on our YouTube channel.
Overall, Swiss Medica considers 70-80% of autistic patient outcomes a success. We consider a patient’s therapy successful if it has resulted in the enhancement of any symptoms, regardless of how modest or profound the improvement. Actual results for an application of therapy range from mild relief of one symptom to an utter transformation of the autistic individual’s quality of life.
These rates are based on patient evaluations and follow-ups and from the Swiss Medica clinic’s filings in Moscow and Belgrade.
Since patients with autism are most often children, their own (autologous) stem cells are not used. We use a combination of allogeneic (donor) multipotent mesenchymal stromal cells (MSCs) from two sources – donated placenta and umbilical cord.
This combination offers a large number of high-quality stem cells without an invasive procedure being required for their collection (such as bone marrow biopsy or liposuction). Stem cells from the umbilical cord and placenta offer strong potential therapeutic properties which are further described in the article sponsored by the National Institute of Health .
All cell products used in Swiss Medica are prepared in our own laboratory and are tested for sterility and a sufficient number of viable cells.
To understand how the child responds to stem cell treatment, to see if the therapy will be helpful, a test procedure is conducted in our clinic. This is a single intravenous administration of placental MSCs at 2 million cells for each kilogram of bodyweight. We track feedback from the patient’s loved ones over 6-8 weeks and evaluate the results on certain parameters.
If the child responds positively to therapy and shows signs of improvement, the patient eligible for a full treatment course, which includes a double intravenous infusion (IV drip) of the cell product combination.
Treatment of autism with cell-based products in our clinics is available for children 4 years of age and older. The treatment also requires a minimum bodyweight of 18kg (40lbs).
Adult patients with autism may also seek stem cell therapy . However, the likelihood of improvement seems to be more limited as the patient ages when compared to younger patients.
Typically, symptoms noticeably decrease after 6-8 weeks following stem cell treatment for autism. Some symptoms may show signs of improvement much earlier, even under 1 week, though this is rare.
Get a free online consultation from a Medical Advisor to learn about expected results for your case >>>
Most frequently, the reported developments are related to social interaction and communication skills. These social improvements appear to be permanent as they show no signs of regression long after treatment.
The most common side effect is an acute reaction to the introduction of stem cells, manifested in a short-term slight increase in temperature (short-term fever), trembling, and sweating.
These reactions are observed in the range of 15 minutes to 3 hours after the cell introduction, are rare (less than 5% of patients), and pass independently and without consequence.
A slight increase in hyperactivity in the first three months can also be observed in some patients. This behavior usually subsides within 6 months and does not interfere with overall improvement. Such hyperactivity has been conjectured to be attributed to improved blood and oxygen flow to the brain, the increased rate of the formation of neural connections, and the increased synaptic activity of previously lesser-utilized regions of the brain .
The specialists at the clinic carefully examine each patient and their medical history in order to make an informed decision regarding the likelihood of positive changes you could expect from stem cell therapy. We do not offer or provide treatment to those patients whose health condition indicates a low probability of successful treatment outcomes. To get advice from our Medical Advisor, contact us through the website or request a callback.
– Published on October 09, 2019
List of References:
. Stem cells and modeling of autism spectrum disorders. Beatriz C.G. Freitas, Cleber A. Trujillo, Cassiano Carromeu, Marianna Yusupova, Roberto Herai, and Alysson R. Muotri. Experimental Neurology. 2014 Oct; 0: 33–43.
. Stem cell therapy in autism: recent insights. Dario Siniscalco, Suresh Kannan, Neomar Semprún-Hernández, Adrien A Eshraghi, Anna Lisa Brigida, and Nicola Antonucci. Stem Cells Cloning. 2018; 11: 55–67.
. Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells. Liang C.M., Weng S.J., Tsai T.H., Li I.H., Lu P.H., Ma K.H., Tai M.C., Chen J.T., Cheng C.Y., Huang Y.S. Cytotherapy. 2014 Oct;16(10):1371-83.
. Proangiogenic Compositions of Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells. Jianying Chen, Zhenjun Liu, Mian Ming Hong, Hongzhe Zhang, Can Chen, Mengyuan Xiao, Junxian Wang, Feng Yao, Mingchuan Ba, Jinghu Liu, Zi-Kuan Guo, and Jixin Zhong. PLoS One. 2014; 9(12): e115316.
. White Matter Tract Changes Associated with Clinical Improvement in an Open-Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism. Carpenter K.L.H , Major S., Tallman C., Chen L.W., Franz L., Sun J., Kurtzberg J., Song A., Dawson G. Stem Cells Translational Medicine. 2019 Feb;8(2):138-147.
. Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy. Samantha F. H. de Witte, Marcella Franquesa, Carla C. Baan, and Martin J. Hoogduijn. Frontiers in Immunology. 2015; 6: 648.
.Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. Yong-Tao Lv, Yun Zhang, Min Liu, Jia-na-ti Qiuwaxi, Paul Ashwood, Sungho Charles Cho, Ying Huan, Ru-Cun Ge, Xing-Wang Chen, Zhao-Jing Wang, Byung-Jo Kim, and Xiang Hu. Journal of Translational Medicine. 2013; 11: 196.
. Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study. Alok Sharma, Nandini Gokulchandran, Hemangi Sane, Anjana Nagrajan, Amruta Paranjape, Pooja Kulkarni, Akshata Shetty, Priti Mishra, Mrudula Kali, Hema Biju, and Prerna Badhe. Stem Cells International. 2013; 2013: 623875.
. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Ding D.C., Chang Y.H., Shyu W.C., Lin S.Z. Cell Transplant. 2015;24(3):339-47.
. Therapeutic Effects of Cellular Therapy in a Case of Adult Autism Spectrum of Disorder. Alok Sharma, Nandini Gokulchandran, Hemangi Sane, Pooja Kulkarni, Samson Nivins, Maitree Maheshwari, Prerna Badhe.
Our primary task is to make your own cells treat your own body. We use advanced technology to activate mesenchymal stem cells derived from adipose tissue, bone marrow, etc. Donated cells can also be used. Introduced to the patient’s body, these cells help to regenerate damaged tissue. Symptoms become less obvious and/or disappear.
*Patient feedback, articles and testimonials provided on this site are for informational purposes only and should not be considered as a guaranteed result for every case of illness. The treatment result depends on the disease, patient’s condition, number of treatment procedures, etc.
All form fields are required.